Azithromycin Eye Drop Dosing
For bacterial conjunctivitis, azithromycin 1% ophthalmic solution (AzaSite) should be dosed as 1 drop in the affected eye(s) twice daily (8-12 hours apart) for the first 2 days, followed by 1 drop once daily for the next 5 days, totaling 9 drops per infected eye over 7 days. 1
Standard Dosing Regimen
The FDA-approved dosing schedule for azithromycin 1% ophthalmic solution is straightforward:
- Days 1-2: 1 drop twice daily (morning and evening, 8-12 hours apart)
- Days 3-7: 1 drop once daily (any time during the day)
- Total treatment duration: 7 days
- Total drops per infected eye: 9 drops 1
This regimen is specifically indicated for bacterial conjunctivitis caused by susceptible organisms including Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus mitis group, and CDC coryneform group G 1.
Administration Technique
Critical steps to ensure proper dosing:
- Shake the closed bottle firmly while held upside down before each use to move medication into the tip 1
- Avoid touching the dropper tip to the eye, fingers, or other surfaces to prevent contamination
- If a drop misses the eye, repeat the attempt
- Wash hands before each administration 1
Storage Requirements
Important storage considerations that affect medication viability:
- Unopened bottles: Refrigerate at 2°-8°C (36°-46°F)
- After opening: Store at 2°-25°C (36°-77°F) for up to 14 days maximum
- Discard after 14 days from opening, even if medication remains 1
Clinical Context
The pharmacokinetic profile supports this dosing schedule. Azithromycin 1% achieves high conjunctival tissue concentrations (peak 559.7 μg/g) that are sustained 1-2 orders of magnitude higher than fluoroquinolones throughout the 7-day treatment period and persist for at least 7 days after completion 2. The extended half-life in conjunctival tissue (65.7 hours) allows for the reduced dosing frequency after the initial 2 days while maintaining therapeutic levels well above the MIC90 for target pathogens 2.
Important Caveats
- For topical ophthalmic use only - this is not the systemic azithromycin dosing used for chlamydial conjunctivitis 1
- Patients should not wear contact lenses during treatment if signs/symptoms of bacterial conjunctivitis are present 1
- The most common adverse reaction is eye irritation (1-2% of patients) 1
- This dosing applies to bacterial conjunctivitis; systemic azithromycin (1 g oral single dose) is required for chlamydial conjunctivitis 3
Do not confuse topical azithromycin eye drops with oral azithromycin for sexually transmitted conjunctivitis - these are entirely different treatment protocols for different conditions.